Epidemiological aspects of the association of the hypertriglyceridemic waist phenotype with metabolic syndrome and cardiovascular risk factors in Morocco. Case the Amazigh population from a geographic region called Souss

• Autorzy: Najeh H. , Rherissi B. , Dwassy Y. , Belmouden A. , Chadli S.
• Języki publikacji: EN

Abstrakty

EN

Background. The global prevalence of metabolic syndrome (MetS) increases susceptibility to non-communicable diseases such as obesity, type 2 diabetes, and cardiovascular disease, posing significant health risks. Effective prevention and management require objective tools. The hypertriglyceridemic waist (TG+WC+) phenotype is proposed as a less expensive approach to identify individuals with metabolic syndrome and other cardiovascular risk factors. Objective. The current aim of this investigation is to study the epidemiological characteristics of the hypertriglyceridemic waist phenotype and their correlations with cardiovascular risk factors and MetS in the Moroccan Amazigh ethnic group from the Souss region of Morocco. Material and Methods. A total of 827 Amazigh adults from the Sousse region of Morocco were divided into four distinct phenotype groups: TG-WC-, TG+WC-, TG-WC+, and TG+WC+ (normal TG- or high TG+ triglycerides/normal WC- or high WC+ waist circumference). The association of the different phenotypes with MetS and other cardiovascular risk factors was established by logistic regression analysis. Results. The prevalence of the TG+WC+ phenotype was 27.7% and varied according to age group and sex. Among subjects with the TG+WC+ phenotype, most were 41-60 years old (53.3%) and in women (74.2%). Participants with the TG+WC+ phenotype had the highest prevalence of dyslipidemia (87.3%), hypoHDLaemia (69.9%), and general obesity (37.12%). The three phenotypes TG-WC-, TG+WC- and TG-WC+ were less associated with MetS and other cardiovascular risk factors. Moreover, people with the TG+WC+ phenotype had a very high odds ratio for MetS. Conclusion. These findings suggest that the TG+WC+ phenotype exhibits a robust correlation with MetS and additional variables connected to cardiovascular risk. The TG+WC+ phenotype serves as a valuable clinical instrument for detecting individuals vulnerable to MetS and cardiovascular diseases.

• Wydawca: -
• Czasopismo: Roczniki Państwowego Zakładu Higieny
• Rocznik: 2024
• Tom: 75
• Numer: 2
• Opis fizyczny: p.185-193,fig.,ref.

Twórcy

autor

Najeh H.

• Cellular Biology and Molecular Genetics Laboratory, Sciences Faculty, Ibn Zohr University, 80000, Agadir, Morocco

autor

Rherissi B.

• Cellular Biology and Molecular Genetics Laboratory, Sciences Faculty, Ibn Zohr University, 80000, Agadir, Morocco

autor

Dwassy Y.

• Medical Biology Unit, Provincial Hospital Hassan 1er, Tiznit, Morocco

autor

Belmouden A.

• Cellular Biology and Molecular Genetics Laboratory, Sciences Faculty, Ibn Zohr University, 80000, Agadir, Morocco

autor

Chadli S.

• Cellular Biology and Molecular Genetics Laboratory, Sciences Faculty, Ibn Zohr University, 80000, Agadir, Morocco
• Sciences of Health and Environment Laboratory, Team of Biotechnology, Environment and Health, Higher Institute of Nursing Professions and Health Techniques (ISPITS), Morocco

Bibliografia

• 1. Xu H, Li X, Adams H, Kubena K, Guo S. Etiology of Metabolic Syndrome and Dietary Intervention. Int J Mol Sci. 2018;20(1):128. doi: 10.3390/ijms20010128.
• 2. Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924. doi: 10.1016/j.diabres.2022.109924.
• 3. Chadli S, Taqarort N, Houate BE, Oulkheir S. Epidemiological transition in Morocco (1960-2015). Médecine Santé Trop. 2018;28(2):201-205. doi: 10.1684/mst.2018.0800.
• 4. De Vries TI, Cooney MT, Selmer RM, Hageman SHJ, Pennells LA, Bois A, et al. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455-2467. doi: 10.1093/eurheartj/ehab312.
• 5. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
• 6. Mensah GA, Fuster V, Murray CJL, Roth GA, Abate Y H, Abbasian M, et al. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol. 2023;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007.
• 7. Najeh H, Rherissi B, Ezzikouri S, Belmouden A, Chadli S. Genetic study of the metabolic syndrome in the Moroccan population: A scoping review. E3S Web Conf. 2023;460:11014. doi: 10.1051/e3sconf/202346011014.
• 8. Rguibi M, Belahsen R. Metabolic syndrome among Moroccan Sahraoui adult women. Am J Hum Biol. 2004;16(5):598-601. doi: 10.1002/ajhb.20065.
• 9. Harraqui K, Oudghiri DE, Hannoun Z, Naceiri Mrabti H, Aboulghras S, Assaggaf H, et al. Frequency of Metabolic Syndrome and Study of Anthropometric, Clinical and Biological Characteristics in Peri- and Postmenopausal Women in the City of Ksar El Kebir (Northern Morocco). Int J Environ Res Public Health. 2022;19(10):6109. doi:10.1002/ajhb.20065.
• 10. Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777-822. doi: 10.3390/ijerph19106109.
• 11. Samson SL, Garber AJ. Metabolic Syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1-23. doi: 10.1016/j.ecl.2013.09.009.
• 12. Engin A. The Definition and Prevalence of Obesity and Metabolic Syndrome. In: Obesity and Lipotoxicity. (Engin AB, Engin A. eds). Advances in Experimental Medicine and Biology Springer International Publishing: Cham; 2017; pp. 1-17. doi: 10.1007/978-3-319-48382-5_1.
• 13. Zhu S, Wang ZM, Heshka S, Heo M, Faith MS, Heymsfield SB. Waist circumference and obesityassociated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002;76(4):743-749. doi:10.1093/ajcn/76.4.743.
• 14. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173(2):307-312. doi: 10.1016/j.atherosclerosis.2003.12.022.
• 15. Lee BJ, Kim JY. Identification of metabolic syndrome using phenotypes consisting of triglyceride levels with anthropometric indices in Korean adults. BMC Endocr Disord. 2020;20:29. doi: 10.1186/s12902-020-0510-0.
• 16. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev Off J Int Assoc Study Obes. 2002;3(3):141-146. doi: 10.1046/j.1467-789X.2002.00065.x.
• 17. Lemieux I, Poirier P, Bergeron J, Alméras N, Lamarche B, Cantin B, et al. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol. 2007;23(Suppl B):23B-31B. doi: 10.1016/S0828-282X(07)71007-3.
• 18. Sam S, Haffner S, Davidson MH, D’Agostino Sr RB, Feinstein S, Kondos G, et al. Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes. Diabetes Care. 2009;32(10):1916-1920. doi: 10.2337/dc09-0412.
• 19. Laurent-Jaccard A. Is excess weight a cardiovascular risk factor? Rev Med Suisse. 2002;2383:542-544. doi: 10.53738/REVMED.2002.-2.2383.0542.
• 20. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102(2):179-184. doi: 10.1161/01.CIR.102.2.179.
• 21. Chen S, Guo X, Yu S, Yang H, Sun G, Li Z, et al. Hypertriglyceridemic waist phenotype and metabolic abnormalities in hypertensive adults. Medicine (Baltimore) 2016;95(49):e5613. doi: 10.1097/MD.0000000000005613.
• 22. Shi WR, Wang HY, Chen S, Guo XF, Li Z, Sun YX. Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study. Lipids Health Dis. 2018;17(1):236. doi: 10.1186/s12944-018-0886-2.
• 23. Li K, Cao B, Ke J, Yang L, Zhao D. Association of Hyper-Triglyceridemic Waist Phenotype and Diabetic Vascular Complication in the Chinese Population. Diabetes Metab Syndr Obes [Internet]. 2023;16:2233-41. doi: 10.2147/DMSO.S416668.
• 24. Lee BJ, Nam J, Kim JY. Predictors of metabolic abnormalities in phenotypes that combined anthropometric indices and triglycerides. BMC Complement Altern Med. 2016;16:59. doi: 10.1186/s12906-016-1024-1.
• 25. de Cuevillas B, Alvarez-Alvarez I, Riezu-Boj JI, Navas-Carretero S, Martinez JA. The hypertriglyceridemicwaist phenotype as a valuable and integrative mirror of metabolic syndrome traits. Sci Rep [Internet]. 2021;11:21859. doi: 10.1038/s41598-021-01343-x.
• 26. Xiang Y, Zhou W, Duan X, Fan Z, Wang S, Liu S, et al. Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women. Front Endocrinol. 2020;10:905. doi: 10.3389/fendo.2019.00905.
• 27. Czernichow S, Bruckert E, Bertrais S, Galan P, Hercberg S, Oppert JM. Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int J Obes. 2007;31(5):791-796. doi: 10.1038/sj.ijo.0803477.
• 28. Thomas MC, Zimmet P, Shaw JE. Identification of Obesity in Patients With Type 2 Diabetes From Australian Primary Care: The NEFRON-5 Study. Diabetes Care. 2006;29(12):2723-2725. doi: 10.2337/dc06-1288.
• 29. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation. 2009;120(16):1640-1645. doi: 10.1161/CIRCULATIONAHA.109.192644.
• 30. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. Guía de práctica clínica de la ESH/ESC para el manejo de la hipertensión arterial (2013). Hipertens Riesgo Vasc. 2013;30:4-91. doi: 10.1016/S1889-1837(13)70027-8.
• 31. Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Pland – 2022 Update. Endocr Pract. 2022;28(10):923-1049. doi: 10.1079/BJN19910073.
• 32. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991;65(2):105-114. doi: 10.1079/BJN19910073.
• 33. Arsenault BJ, Lemieux I, Després JP, Wareham NJ, Kastelein JJ, Khaw KT et al. The hypertriglyceridemicwaist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk Prospective Population Study. CMAJ Can Med Assoc J. 2010;182(13):1427-1432.doi: 10.1503/cmaj.091276.
• 34. Amadi CE, Mbakwem AC, Duro DC, Udenze IC, Akinsola CM, Ajuluchukwu JN, et al. Prevalence, patterns and predictors of metabolic abnormalities in Nigerian hypertensives with hypertriglyceridemic waist phenotype: A cross sectional study. PLOS Glob Public Health. 2022;2(12):e0001203. doi: 10.1371/journal. pgph.0001203.
• 35. Xuan Y, Shen Y, Wang S, Gao P, Gu X, Tang D, et al. The association of hypertriglyceridemic waist phenotype with hypertension: A cross‐sectional study in a Chinese middle aged‐old population. J Clin Hypertens. 2022;24(2):191-199. doi: 10.1111/jch.14424.
• 36. Wang A, Li Z, Zhou Y, Wang C, Luo Y, Liu X, et al. Hypertriglyceridemic waist phenotype and risk of cardiovascular diseases in China: results from the Kailuan Study. Int J Cardiol. 2014;174(1):106-109. doi: 10.1016/j.ijcard.2014.03.177.
• 37. Zheng X, Ren X, Jiang M, Han L. Association between hypertriglyceridemic-waist phenotype and cardiovascular disease: A cohort study and metaanalysis. Front Cardiovasc Med. 2022;9:940168. doi: 10.3389/fcvm.2022.940168.
• 38. Fernández-García JC, Muñoz-Garach A, Martínez-González MÁ, Salas-Salvado J , Corella D, Hernáez Á, et al. Association Between Lifestyle and Hypertriglyceridemic Waist Phenotype in the PREDIMED-Plus Study. Obes Silver Spring Md. 2020;28(3):537-543. doi: 10.1002/oby.22728.
• 39. Prakaschandra R, Naidoo DP. The association between the hypertriglyceridaemia waist phenotype, cardiovascular risk factors and the metabolic syndrome in South African Asian-Indians. Diabetes Metab Syndr Clin Res Rev. 2022;16(6):102524. doi: 10.1016/j.dsx.2022.102524.
• 40. Gazi IF, Filippatos TD, Tsimihodimos V, Saougos VG, Liberopoulos EN, Mikhailidis DP, et al. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids. 2006;41(7):647-654. doi: 10.1007/s11745-006-5015-8.
• 41. Dikaiakou E, Athanasouli F, Fotiadou A, Kafetzi M, Fakiolas S, Michalacos S, et al. Hypertriglyceridemic Waist Phenotype and Its Association with Metabolic Syndrome Components, among Greek Children with Excess Body Weight. Metabolites. 2023 Feb 3;13(2):230. doi: 10.3390/metabo13020230.
• 42. Ma CM, Liu XL, Lu N, Wang R, Lu Q, and Yin FZ. Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis. Endocrine. 2019;64(3):469-485. doi: 10.1007/s12020-019-01945-6.
• 43. Wang A, Li Z, Zhou Y, Wang C, Luo Y, Liu X, et al. Hypertriglyceridemic waist phenotype and risk of cardiovascular diseases in China: results from the Kailuan Study. Int J Cardiol. 2014;174(1):106-109. oi: 10.1016/j.ijcard.2014.03.177

Identyfikatory

DOI

10.32394/rpzh/190852